Repaglinide Tablet
Product Images NDC 71335-2554

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Repaglinide (NDC 71335-2554). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352554)

Each tablet contains Repaglinide USP 0.5 mg. This medication should be stored at 20° to 25°C (68° to 77°F) and protected from moisture. It is important to keep the bottles tightly closed and out of reach of children. The dosage information can be obtained by scanning the package insert QR code for comprehensive details. This particular product contains 30 tablets and should be dispensed in a tight container with child-resistant closure. This medication is available by prescription only. Manufactured by Bryant Ranch Prepack, Inc. for Macleods Pharmaceuticals. [NDC 71335-2554-1]*

FDA Label Image

505 (Repaglinide Figure 1)

This is a chart showing the change in HbA1c (%) over treatment weeks for Pioglitazone. It displays the comparison between pepaginice and pypaginice forms of Pioglitazone.*

FDA Label Image

Str (Repaglinide Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.